ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates

    L. Thalji1, N. Thalji2, S. Ibrahim3, J. Heimbach2, P. Kamath4, D. Haile1, D. Kor1

    1Anesthesiology, Mayo Clinic, Rochester, MN, 2Surgery, Mayo Clinic, Rochester, MN, 3Pediatric Gastroenterology, Mayo Clinic, Rochester, MN, 4Gastroenterology, Mayo Clinic, Rochester, MN

    *Purpose: Pre-transplant hypernatremia has been shown to predict post-transplant mortality in adult liver transplant (LT) recipients. The effects of hypernatremia in children, however, remain unexplored.…
  • 2020 American Transplant Congress

    Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience

    S. Hassan1, K. Mysore1, D. N. Cerminara2, K. E. Hosek3, M. Faraone4, R. Sigereddi5, R. Ackah5, A. Rana6, J. Goss6, T. Galvan6

    1Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 2Pharmacy, Texas Children's Hospital, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 3Outcomes and Impact Service, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 4Department of Surgery, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 5Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 6Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX

    *Purpose: Pediatric liver transplantation (LT) is an established treatment for a myriad of liver diseases most notably biliary atresia and urea cycle defects. In the…
  • 2020 American Transplant Congress

    Limited Differences in Infectious Complications of Pediatric Liver Transplant between Hepatoblastoma and Non-Hepatoblastoma Patients

    H. Hendricks, A. Lane, J. Geller, A. Bondoc, A. Taylor, G. Paulsen, S. Hirth, S. Blum, G. Tiao, L. Danziger-Isakov

    Cincinnati Children's Hosp Med Cntr, Cincinnati, OH

    *Purpose: Pediatric liver transplantation (pLTX) has become a part of treatment for Hepatoblastoma (HB). The incidence and characterization of infectious events (IE) has not been…
  • 2020 American Transplant Congress

    New Concept of Liver Transplatation in Pediatric Patient – Up Side Down Metod

    P. Dubska, L. Janousek, J. Chlupac, M. Kocik, J. Fronek

    Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Liver transplantation (LTx) in pediatrics has become an accepted modality for treatment in end-stage liver disease and irreversible acute liver failure. Left lateral segment…
  • 2020 American Transplant Congress

    Understanding Attitudes and Perceptions about Liver Disease and Living-Donor Liver Transplant- Results of a National Survey

    C. Zell1, C. Caruso1, T. Kirby2, S. Piccirilli3, S. Ganesh4, J. Whyte5, A. Humar3

    1Clinical Marketing, UPMC, Pittsburgh, PA, 2Marketing Intelligence, UPMC, Pittsburgh, PA, 3Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, 4Clinical Marketing, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, 5WebMD, New York, NY

    *Purpose: There are more than 14,000 people on the national waiting list for a liver transplant. Approximately 25% will die before receiving a life-saving transplant…
  • 2020 American Transplant Congress

    De Novo Dosing and Trough Attainment Trends of Extended-Release Tacrolimus in the Absence of Dose Adjustments

    M. J. Moritz1, D. R. Stevens2, U. Meier-Kriesche2, T. A. Horwedel2

    1Department of Surgery, Lehigh Valley Health Network, Allentown, PA, 2Veloxis Pharmaceuticals, Cary, NC

    *Purpose: Initial dosing of tacrolimus extended-release tablets (LCPT) was 0.17 mg/kg/day in the pivotal trial in de novo kidney transplant recipients. Dosing subsequent to the…
  • 2020 American Transplant Congress

    Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population

    S. Suh, Y. Choi

    Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of

    *Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…
  • 2020 American Transplant Congress

    A Comparative Analysis of Mucormycosis in Solid Organ Transplant Recipients and Other Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes

    T. Zangeneh1, J. Bardwell2, R. Bouzigard3, B. Youssefi2, C. Le4, M. Al-Obaidi2

    1Internal Medicine / Division of Infectious Diseases, University of Arizona, Tucson, AZ, 2Internal Medicine / Division of Infectious Diseases, Banner University Medical Center, Tucson, AZ, 3Internal Medicine, Banner University Medical Center, Tucson, AZ, 4Department of Otolaryngology, University of Arizona, Tucson, AZ

    *Purpose: Mucormycosis is a rare disease that is associated with a high morbidity and mortality. It usually affects those with uncontrolled diabetes mellitus (DM) and…
  • 2020 American Transplant Congress

    Pentamidine Prophylaxis in Transplant Recipients

    B. Summers, A. Morrison, N. Sulejmani, R. Kenney

    Department of Pharmacy, Henry Ford Hospital, Detroit, MI

    *Purpose: Trimethoprim-sulfamethoxazole (TMP-SMX) is preferred therapy for pneumocystis pneumonia (PJP) prophylaxis in solid organ transplant (SOT) recipients, however, use can be limited by allergy and…
  • 2020 American Transplant Congress

    Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients

    R. Odrobina1, B. Tritle2, C. A.Gomez1

    1Division of Infectious Diseases, University of Utah, Salt Lake City, UT, 2Department of Pharmacy, University of Utah, Salt Lake City, UT

    *Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…
  • « Previous Page
  • 1
  • …
  • 424
  • 425
  • 426
  • 427
  • 428
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences